Athira Pharma, Inc. (ATHA) Tops Q2 EPS by 4c
Get Alerts ATHA Hot Sheet
Join SI Premium – FREE
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- UBS Upgrades Stockland (SGP:AU) (STKAF) to Buy
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share